1-20 of 129
Sort by
News

Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist

Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist
News

miRNA Identified as Potential ITP Diagnostic Biomarker

Leah Lawrence
Published: 2025
Abstract
April 2025
View News titled, miRNA Identified as Potential ITP Diagnostic Biomarker
News

Fitusiran on the Horizon for Hemophilia

Published: 2025
Abstract
March 2025
View News titled, Fitusiran on the Horizon for Hemophilia
News

AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia

Leah Lawrence
Published: 2025
Abstract
March 2025
View News titled, AI-Assisted POCUS Could Help Identify Joint Bleeds in Hemophilia
News

Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)

Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Bevacizumab in Hereditary Hemorrhagic Telangiectasia (TRUST-HHT; NCT04404881)
News

High Incidence of Postpartum Hemorrhage Seen in Hemophilia Carriers

Ruth Jessen Hickman, MD
Published: 2024
Abstract
January 2025
View News titled, High Incidence of Postpartum Hemorrhage Seen in Hemophilia Carriers
News

Pomalidomide Found Safe, Highly Effective for Epistaxis in HHT

Ruth Jessen Hickman, MD
Published: 2024
Abstract
January 2025
View News titled, Pomalidomide Found Safe, Highly Effective for Epistaxis in HHT
News

Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A

Anna Azvolinsky, PhD
Published: 2024
Abstract
Mid-November 2024
View News titled, Experts Release Guidance on Liver-Related Toxicities With Gene Therapy for Hemophilia A
News

Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia
News

Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis

Katie Robinson
Published: 2024
Abstract
February 2024
View News titled, Etranacogene Dezaparvovec Bests Extended Half-Life Factor IX Products in Hemophilia B Prophylaxis
News

Health Disparities Persist in Hemophilia Life Expectancy

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2024
View News titled, Health Disparities Persist in Hemophilia Life Expectancy
News

Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer

Ruth Jessen Hickman, MD
Published: 2023
Abstract
January 2024
View News titled, Better Scoring Systems Needed for Bleeding Risk Assessment in Patients With Cancer
News

Age Linked to Desmopressin Response in von Willebrand Disease

Thomas R. Collins
Published: 2023
Abstract
January 2024
View News titled, Age Linked to Desmopressin Response in von Willebrand Disease
News

Emicizumab Effective as a Hemophilia A Prophylaxis in Infants

Leah Lawrence
Published: 2023
Abstract
January 2024
View News titled, Emicizumab Effective as a Hemophilia A Prophylaxis in Infants
News

Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia

Ruth Jessen Hickman, MD
Published: 2023
Abstract
December 2023
View News titled, Ultrasound May Be Useful to Assess Subclinical Synovial Inflammation in Hemophilia
News

Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A

Katie Robinson
Published: 2023
Abstract
October 2023
View News titled, Valoctocogene Roxaparvovec May Provide Lower Bleeding Rates Than Emicizumab in Severe Hemophilia A
News

Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development

Anna Azvolinsky, PhD
Published: 2023
Abstract
September 2023
View News titled, Switching to Different FVIII Product Not Associated with Anti-FVIII Inhibitor Development
News

Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B

Brandon May
Published: 2023
Abstract
Mid-July 2023
View News titled, Fitusiran Significantly Reduces Bleeding Events, Improves HRQoL in Hemophilia A, B
News

STASEY Study Confirms Safety of Emicizumab Prophylaxis in Hemophilia A With FVIII Inhibitors

By Khylia Marshall
Published: 2023
Abstract
March 2023
View News titled, STASEY Study Confirms Safety of Emicizumab Prophylaxis in Hemophilia A With FVIII Inhibitors
News

Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?

Kimberly J. Retzlaff
Published: 2023
Abstract
March 2023
View News titled, Which Modality Is Preferred in Hemophilia: Factor or Non-Factor Prophylaxis?